• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Government warns on cybersecurity issue with Fresenius Kabi’s Agilia Connect infusion system

December 21, 2021 By Sean Whooley

Fresenius Kabi logo updatedThe U.S. Cyber Security & Infrastructure Security Agency today issued a medical advisory for the Fresenius Kabi Agilia Connect infusion system.

Fresenius Kabi’s Agilia Connect infusion system has been deemed “exploitable remotely/low attack complexity” by the agency. Successful exploitation of vulnerabilities could allow an attacker to gain access to sensitive information, modify settings or parameters or perform arbitrary actions as an authenticated user.

The vulnerabilities highlighted by CISA include uncontrolled resource consumption, use of a broken or risky cryptographic algorithm, insufficiently protected credentials, improper access control, plaintext storage of a password, files or directories accessible to external parties, exposure of information through directory listing, cross-site scripting, injection, use of hard-coded credentials, use of client-side authentication and use of unmaintained third-party components, according to a CISA news release.

Affected products include the Agilia Connect WiFi module for the vD25 pumps and prior pumps, the Agilia Link+ V3.0 D15 and prior, Vigilant Software Suite v1.0: Vigilant Centerium, Vigilant MasterMed and Vigilant Insight and the Agilia Partner maintenance software v3.3.0 and prior.

Fresenius Kabi initiated communication on the issue in April 2021 to inform users of the availability of new versions of the products that address the vulnerabilities.

The company also identified that early Link+ devices (approximately 1,200) would need hardware change to support D16 (a new version) or later firmware. Until those devices can be replaced, Fresenius Kabi said to follow CISA’s recommendations:

  • Minimize network exposure for all control system devices and/or systems, and ensure they are not accessible from the Internet.
  • Locate control system networks and remote devices behind firewalls and isolate them from the business network.
  • When remote access is required, use secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as its connected devices.

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: freseniuskabi, infusion pump, infusion systems

IN CASE YOU MISSED IT

  • 1nhaler raises $2M for cardboard inhaler device
  • Embecta expands partnership with Direct Relief to support diabetes initiatives on World Diabetes Day
  • What diabetes tech companies are doing on World Diabetes Day 2025
  • Dexcom unveils new advocates to support World Diabetes Day campaign
  • Renu MedTech introduces tubeless insulin patch pump in India

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS